New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Objective Primary:
Determine the objective response rate in patients with advanced gallbladder treated with new
Chemotherapy regimen
Secondary:
Determine time to progression-free survival and overall survival of patients treated with
this regimen.
Determine quality of life of patients treated with this regimen. Determine the toxicity of
new chemotherapy regimen
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Collaborators:
Affiliated Hospital of Qinghai University Air Force Military Medical University, China Capital Medical University China Medical University, China Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Eastern Hepatobiliary Surgery Hospital First Affiliated Hospital of Chongqing Medical University First People's Hospital of Kunming Fourth Military Medical University Jilin University LanZhou University Peking University First Hospital Qilu Hospital Qilu Hospital of Shandong University Qinghai People's Hospital Qinghai University Shandong Provincial Hospital Shanghai Changzheng Hospital Shengjing Hospital Southwest Hospital, China Tang-Du Hospital The First Affiliated Hospital of Dalian Medical University The First Affiliated Hospital of Kunming Medical College The first clinical college of harbin medical university The first people's hospital of Guiyang The first people’s hospital of Guiyang The people's hospital of Heilongjiang province The people’s hospital of Heilongjiang province The Second Affiliated Hospital of Harbin Medical University Tianjin Medical University Cancer Institute and Hospital Xi'an Central Hospital Xuanwu Hospital, Beijing